Accepted for Publication: April 2, 2021.
Published Online: June 14, 2021. doi:10.1001/jamaneurol.2021.1707
Corresponding Author: Amrou Sarraj, MD, Department of Neurology, The University of Texas McGovern Medical School, 6431 Fannin St, Medical School Bldg 7.044, Houston, TX 77030 (amrou.sarraj@uth.tmc.edu).
Author Contributions: Dr Sarraj had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Sarraj, Kamal, Cai, Alenzi, Day.
Acquisition, analysis, or interpretation of data: Sarraj, Goyal, Chen, Grotta, Blackburn, Requena, Kamal, Abraham, Elijovich, Dannenbaum, Mir, Tekle, Pujara, Shaker, Maali, Radaideh, Reddy, Parsha, Alenzi, Abdulrazzak, Greco, Hoit, Martin-Schild, Song, Sitton, Tsivgoulis, Alexandrov, Arthur, Day, Hassan, Ribo.
Drafting of the manuscript: Sarraj, Blackburn, Kamal, Alenzi, Greco, Martin-Schild.
Critical revision of the manuscript for important intellectual content: Goyal, Chen, Grotta, Requena, Kamal, Abraham, Elijovich, Dannenbaum, Mir, Tekle, Pujara, Shaker, Cai, Maali, Radaideh, Reddy, Parsha, Alenzi, Abdulrazzak, Hoit, Martin-Schild, Song, Sitton, Tsivgoulis, Alexandrov, Arthur, Day, Hassan, Ribo. Statistical analysis: Pujara, Parsha, Alenzi.
Administrative, technical, or material support: Sarraj, Chen, Abraham, Mir, Tekle, Parsha, Arthur, Day.
Supervision: Sarraj, Blackburn, Elijovich, Dannenbaum, Cai, Reddy, Abdulrazzak, Greco, Hassan.
Conflict of Interest Disclosures: Dr Sarraj reported being the principal investigator for the SELECT and SELECT 2 trials, funded by The University of Texas McGovern Medical School through grants from Stryker and serving as a member of the speaker bureau and advisory board for Stryker. Dr Grotta reported consulting for Frazer, Ltd, outside of the submitted work. Dr Abraham reported consulting and lecturing for Stryker outside the submitted work. Dr Elijovich reported consulting for MicroVention, Inc, Balt, Cerenovus, Scientia Ltd, and Viz.ai, Inc, outside the submitted work. Dr Hoit reports personal fees from Medtronic, MicroVention, Inc, and Penumbra, Inc, and grants from Siemens AG outside the submitted work and stock ownership in Cerebrotech Medical Systems, Inc. Dr Arthur reported personal fees from Balt, Johnson & Johnson Services, Inc, Medtronic, MicroVention, Inc, Penumbra, Inc, Scientia Ltd, Siemens, and Stryker outside the submitted work. Dr Hassan reported consulting and speaker fees from Medtronic, Stryker, MicroVention, Inc, Cerenovus, Penumbra, Inc, Balt, Viz.ai, Inc, GE Healthcare, Genentech, Inc, Proximie Limited, and NovaSigna during the conduct of the study. Dr Ribo reported nonfinancial support from Philips NV as the co−principal investigator of the WeTRUST study during the conduct of the study; being cofounder of Anaconda BioMed; ownership in less than 1% of Methinks; consulting for Medtronic, Cerenovus, and Apta Targets; and lecturing for Stryker outside the submitted work. No other disclosures were reported.
1.Goyal
M , Menon
BK , van Zwam
WH ,
et al; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
Lancet. 2016;387(10029):1723-1731. doi:
10.1016/S0140-6736(16)00163-X
PubMedGoogle ScholarCrossref 2.Powers
WJ , Rabinstein
AA , Ackerson
T ,
et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
Stroke. 2019;50(12):e344-e418. doi:
10.1161/STR.0000000000000211
PubMedGoogle ScholarCrossref 9.Ernst
M , Psychogios
M-N , Schlemm
E ,
et al. Modeling the optimal transportation for acute stroke treatment: impact of diurnal variations in traffic rate.
Clin Neuroradiol. 2020. Published online July 16, 2020. doi:
10.1007/s00062-020-00933-yPubMedGoogle Scholar 12.Turc
G , Bhogal
P , Fischer
U ,
et al. European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischaemic stroke endorsed by Stroke Alliance for Europe (SAFE).
Eur Stroke J. 2019;4(1):6-12. doi:
10.1177/2396987319832140
PubMedGoogle ScholarCrossref 13.Barber
PA , Demchuk
AM , Zhang
J , Buchan
AM . Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy: ASPECTS Study Group; Alberta Stroke Programme Early CT Score.
Lancet. 2000;355(9216):1670-1674. doi:
10.1016/S0140-6736(00)02237-6
PubMedGoogle ScholarCrossref 14.Zaidat
OO , Yoo
AJ , Khatri
P ,
et al; Cerebral Angiographic Revascularization Grading (CARG) Collaborators; STIR Revascularization working group; STIR Thrombolysis in Cerebral Infarction (TICI) Task Force. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.
Stroke. 2013;44(9):2650-2663. doi:
10.1161/STROKEAHA.113.001972
PubMedGoogle ScholarCrossref 15.Wahlgren
N , Ahmed
N , Dávalos
A ,
et al; SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.
Lancet. 2007;369(9558):275-282. doi:
10.1016/S0140-6736(07)60149-4
PubMedGoogle ScholarCrossref 21.Abilleira
S , Pérez de la Ossa
N , Jiménez
X ,
et al. Transfer to the local stroke center versus direct transfer to endovascular center of acute stroke patients with suspected large vessel occlusion in the catalan territory (RACECAT): study protocol of a cluster randomized within a cohort trial.
Int J Stroke. 2019;14(7):734-744. doi:
10.1177/1747493019852176PubMedGoogle ScholarCrossref 25.ClinicalTrials.gov. Evaluation of Direct Transfer to Angiography Suite vs Computed Tomography Suite in Endovascular Treatment: Randomized Clinical Trial (ANGIOCAT). NCT04001738. Accessed March 29, 2021.
https://clinicaltrials.gov/ct2/show/NCT04001738